Civil Society Takes Charge On Climate Action As Governments Waver 21/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Youth leaders from around the world clamored for more action on climate change Saturday at a first-ever United Nation’s Youth Climate Summit – even as the actual government commitments lined up for Monday’s formal meeting with heads of state appeared likely fall far short of making the dramatic changes that scientists […] Continue reading -> New International President Takes Reins of MSF 16/09/2019 Editorial team Trauma surgeon and veteran field worker, Christos Christou, has taken over the Médecins Sans Frontières (MSF) reins as International President, following his election by the organization’s International General Assembly last June. Christou, former president of the MSF Greece Board of Directors, will be faced with the leadership challenges of an organization that has grown from […] Continue reading -> WHO To Revisit Guidelines On Ebola Survivors’ Care; Study Finds 5-fold Higher Mortality 06/09/2019 Grace Ren New data revealing that survivors of Guinea’s 2013-16 Ebola outbreak were five times more likely to die within the first year after recovery, as compared to the general population, suggests a need to revisit WHO guidance on Ebola survivors’ monitoring and care, a top WHO official said on Friday. The findings were part of a […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Gavi Says 1.3 Million Doses Of Merck’s Ebola Vaccine Will Be Made Available; MSF Says Field Supply “Extremely Low” & “Sporadic” 23/07/2019 Elaine Ruth Fletcher There is no shortage of Merck’s life-saving Ebola vaccine on the ground in the Democratic Republic of Congo, and more doses will be produced, sufficient to immunise 1.3 million people over the next 6-18 months, a spokesman for Gavi, the Vaccine Alliance, told Health Policy Watch on Tuesday. Meanwhile, Merck, producer of the V920 investigational […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Ebola Emergency Shadowed By Cross-Border Risks, Funding Gaps & Vaccine Challenges 18/07/2019 Elaine Ruth Fletcher Against the background of increased cross-border infection risks, the World Health Organization on Wednesday declared the Ebola virus outbreak in the Democratic Republic of the Congo to be a Public Health Emergency of International Concern (PHEIC) – a decision that may help increase aid flows to the disease epicentre but also threaten free-wheeling patterns of […] Continue reading -> Posts navigation Older postsNewer posts
New International President Takes Reins of MSF 16/09/2019 Editorial team Trauma surgeon and veteran field worker, Christos Christou, has taken over the Médecins Sans Frontières (MSF) reins as International President, following his election by the organization’s International General Assembly last June. Christou, former president of the MSF Greece Board of Directors, will be faced with the leadership challenges of an organization that has grown from […] Continue reading -> WHO To Revisit Guidelines On Ebola Survivors’ Care; Study Finds 5-fold Higher Mortality 06/09/2019 Grace Ren New data revealing that survivors of Guinea’s 2013-16 Ebola outbreak were five times more likely to die within the first year after recovery, as compared to the general population, suggests a need to revisit WHO guidance on Ebola survivors’ monitoring and care, a top WHO official said on Friday. The findings were part of a […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Gavi Says 1.3 Million Doses Of Merck’s Ebola Vaccine Will Be Made Available; MSF Says Field Supply “Extremely Low” & “Sporadic” 23/07/2019 Elaine Ruth Fletcher There is no shortage of Merck’s life-saving Ebola vaccine on the ground in the Democratic Republic of Congo, and more doses will be produced, sufficient to immunise 1.3 million people over the next 6-18 months, a spokesman for Gavi, the Vaccine Alliance, told Health Policy Watch on Tuesday. Meanwhile, Merck, producer of the V920 investigational […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Ebola Emergency Shadowed By Cross-Border Risks, Funding Gaps & Vaccine Challenges 18/07/2019 Elaine Ruth Fletcher Against the background of increased cross-border infection risks, the World Health Organization on Wednesday declared the Ebola virus outbreak in the Democratic Republic of the Congo to be a Public Health Emergency of International Concern (PHEIC) – a decision that may help increase aid flows to the disease epicentre but also threaten free-wheeling patterns of […] Continue reading -> Posts navigation Older postsNewer posts
WHO To Revisit Guidelines On Ebola Survivors’ Care; Study Finds 5-fold Higher Mortality 06/09/2019 Grace Ren New data revealing that survivors of Guinea’s 2013-16 Ebola outbreak were five times more likely to die within the first year after recovery, as compared to the general population, suggests a need to revisit WHO guidance on Ebola survivors’ monitoring and care, a top WHO official said on Friday. The findings were part of a […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Gavi Says 1.3 Million Doses Of Merck’s Ebola Vaccine Will Be Made Available; MSF Says Field Supply “Extremely Low” & “Sporadic” 23/07/2019 Elaine Ruth Fletcher There is no shortage of Merck’s life-saving Ebola vaccine on the ground in the Democratic Republic of Congo, and more doses will be produced, sufficient to immunise 1.3 million people over the next 6-18 months, a spokesman for Gavi, the Vaccine Alliance, told Health Policy Watch on Tuesday. Meanwhile, Merck, producer of the V920 investigational […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Ebola Emergency Shadowed By Cross-Border Risks, Funding Gaps & Vaccine Challenges 18/07/2019 Elaine Ruth Fletcher Against the background of increased cross-border infection risks, the World Health Organization on Wednesday declared the Ebola virus outbreak in the Democratic Republic of the Congo to be a Public Health Emergency of International Concern (PHEIC) – a decision that may help increase aid flows to the disease epicentre but also threaten free-wheeling patterns of […] Continue reading -> Posts navigation Older postsNewer posts
Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Gavi Says 1.3 Million Doses Of Merck’s Ebola Vaccine Will Be Made Available; MSF Says Field Supply “Extremely Low” & “Sporadic” 23/07/2019 Elaine Ruth Fletcher There is no shortage of Merck’s life-saving Ebola vaccine on the ground in the Democratic Republic of Congo, and more doses will be produced, sufficient to immunise 1.3 million people over the next 6-18 months, a spokesman for Gavi, the Vaccine Alliance, told Health Policy Watch on Tuesday. Meanwhile, Merck, producer of the V920 investigational […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Ebola Emergency Shadowed By Cross-Border Risks, Funding Gaps & Vaccine Challenges 18/07/2019 Elaine Ruth Fletcher Against the background of increased cross-border infection risks, the World Health Organization on Wednesday declared the Ebola virus outbreak in the Democratic Republic of the Congo to be a Public Health Emergency of International Concern (PHEIC) – a decision that may help increase aid flows to the disease epicentre but also threaten free-wheeling patterns of […] Continue reading -> Posts navigation Older postsNewer posts
GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Gavi Says 1.3 Million Doses Of Merck’s Ebola Vaccine Will Be Made Available; MSF Says Field Supply “Extremely Low” & “Sporadic” 23/07/2019 Elaine Ruth Fletcher There is no shortage of Merck’s life-saving Ebola vaccine on the ground in the Democratic Republic of Congo, and more doses will be produced, sufficient to immunise 1.3 million people over the next 6-18 months, a spokesman for Gavi, the Vaccine Alliance, told Health Policy Watch on Tuesday. Meanwhile, Merck, producer of the V920 investigational […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Ebola Emergency Shadowed By Cross-Border Risks, Funding Gaps & Vaccine Challenges 18/07/2019 Elaine Ruth Fletcher Against the background of increased cross-border infection risks, the World Health Organization on Wednesday declared the Ebola virus outbreak in the Democratic Republic of the Congo to be a Public Health Emergency of International Concern (PHEIC) – a decision that may help increase aid flows to the disease epicentre but also threaten free-wheeling patterns of […] Continue reading -> Posts navigation Older postsNewer posts
Ebola Outbreak Marks 1 Year With Huge Funding Gap, Questions On Vaccine Strategy 01/08/2019 David Branigan Thursday, 1 August, marked the one-year anniversary of the Ebola outbreak in the Democratic Republic of the Congo (DRC), as daily reports of new infections, including 3 more cases in Goma along DRC’s border with Rwanda, fueled new concerns about regional spread of the deadly disease. Meanwhile, the World Health Organization called on international donors […] Continue reading -> Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Gavi Says 1.3 Million Doses Of Merck’s Ebola Vaccine Will Be Made Available; MSF Says Field Supply “Extremely Low” & “Sporadic” 23/07/2019 Elaine Ruth Fletcher There is no shortage of Merck’s life-saving Ebola vaccine on the ground in the Democratic Republic of Congo, and more doses will be produced, sufficient to immunise 1.3 million people over the next 6-18 months, a spokesman for Gavi, the Vaccine Alliance, told Health Policy Watch on Tuesday. Meanwhile, Merck, producer of the V920 investigational […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Ebola Emergency Shadowed By Cross-Border Risks, Funding Gaps & Vaccine Challenges 18/07/2019 Elaine Ruth Fletcher Against the background of increased cross-border infection risks, the World Health Organization on Wednesday declared the Ebola virus outbreak in the Democratic Republic of the Congo to be a Public Health Emergency of International Concern (PHEIC) – a decision that may help increase aid flows to the disease epicentre but also threaten free-wheeling patterns of […] Continue reading -> Posts navigation Older postsNewer posts
Making Tough Vaccine Choices Amidst The Ebola Public Health Emergency 24/07/2019 Editorial team WHO’s declaration of the Ebola outbreak in the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern has been shadowed by growing questions over vaccine strategy in a crisis that has dragged on for over a year, and now threatens to spread across borders. Until now, a ring vaccination strategy focusing […] Continue reading -> Gavi Says 1.3 Million Doses Of Merck’s Ebola Vaccine Will Be Made Available; MSF Says Field Supply “Extremely Low” & “Sporadic” 23/07/2019 Elaine Ruth Fletcher There is no shortage of Merck’s life-saving Ebola vaccine on the ground in the Democratic Republic of Congo, and more doses will be produced, sufficient to immunise 1.3 million people over the next 6-18 months, a spokesman for Gavi, the Vaccine Alliance, told Health Policy Watch on Tuesday. Meanwhile, Merck, producer of the V920 investigational […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Ebola Emergency Shadowed By Cross-Border Risks, Funding Gaps & Vaccine Challenges 18/07/2019 Elaine Ruth Fletcher Against the background of increased cross-border infection risks, the World Health Organization on Wednesday declared the Ebola virus outbreak in the Democratic Republic of the Congo to be a Public Health Emergency of International Concern (PHEIC) – a decision that may help increase aid flows to the disease epicentre but also threaten free-wheeling patterns of […] Continue reading -> Posts navigation Older postsNewer posts
Gavi Says 1.3 Million Doses Of Merck’s Ebola Vaccine Will Be Made Available; MSF Says Field Supply “Extremely Low” & “Sporadic” 23/07/2019 Elaine Ruth Fletcher There is no shortage of Merck’s life-saving Ebola vaccine on the ground in the Democratic Republic of Congo, and more doses will be produced, sufficient to immunise 1.3 million people over the next 6-18 months, a spokesman for Gavi, the Vaccine Alliance, told Health Policy Watch on Tuesday. Meanwhile, Merck, producer of the V920 investigational […] Continue reading -> DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Ebola Emergency Shadowed By Cross-Border Risks, Funding Gaps & Vaccine Challenges 18/07/2019 Elaine Ruth Fletcher Against the background of increased cross-border infection risks, the World Health Organization on Wednesday declared the Ebola virus outbreak in the Democratic Republic of the Congo to be a Public Health Emergency of International Concern (PHEIC) – a decision that may help increase aid flows to the disease epicentre but also threaten free-wheeling patterns of […] Continue reading -> Posts navigation Older postsNewer posts
DR Congo Health Minister Resigns After President Takes Control Of Ebola Emergency 22/07/2019 Editorial team The Democratic Republic of the Congo’s Health Minister, Oly Iluga, resigned Monday, following his removal Saturday as the head of the country’s Ebola response – after the country’s President Felix Tshisekedi placed management of the crisis under direct presidential supervision. “As a result of your decision to place the response to the Ebola outbreak under […] Continue reading -> Ebola Emergency Shadowed By Cross-Border Risks, Funding Gaps & Vaccine Challenges 18/07/2019 Elaine Ruth Fletcher Against the background of increased cross-border infection risks, the World Health Organization on Wednesday declared the Ebola virus outbreak in the Democratic Republic of the Congo to be a Public Health Emergency of International Concern (PHEIC) – a decision that may help increase aid flows to the disease epicentre but also threaten free-wheeling patterns of […] Continue reading -> Posts navigation Older postsNewer posts
Ebola Emergency Shadowed By Cross-Border Risks, Funding Gaps & Vaccine Challenges 18/07/2019 Elaine Ruth Fletcher Against the background of increased cross-border infection risks, the World Health Organization on Wednesday declared the Ebola virus outbreak in the Democratic Republic of the Congo to be a Public Health Emergency of International Concern (PHEIC) – a decision that may help increase aid flows to the disease epicentre but also threaten free-wheeling patterns of […] Continue reading -> Posts navigation Older postsNewer posts